In recent years, we have seen a growing trend of large corporations acquiring primary care clinics. Earlier this month, the New York Times published an article entitled “Corporate Giants…
Browsing: Business
Almost a year after announcing its intention to acquire a majority stake in M.I.Tech, the South Korean medtech responsible for…
Cleveland, Texas-based Texas Emergency Hospital is the most expensive hospital to receive a colonoscopy, according to information from data analytics…
Editor’s note: This story has been updated with additional information on Pear’s financial state. The assets of prescription digital therapeutics…
Having tasted blockbuster success with its irritable bowel syndrome (IBS) drug Linzess, Ironwood Pharmaceuticals is willing to pay $1 billion…
Though much of Freenome’s focus has been on its blood test for the early detection of colorectal cancer, the company…
For physicians overall, intriguing trends showed up this year — an improvement in gender-based pay disparity in primary care; a…
Envision Healthcare has reached a restructuring agreement with its stakeholders, including ASC management center AmSurg, after announcing plans to file for bankruptcy.…
An industry-first FDA approval for a nonalcoholic steatohepatitis (NASH) therapy may still be a ways off. After reviewing Intercept Pharmaceuticals’…
Whether you believe this this figurative adage or not, it is a hard truth. Money is ubiquitous; it pervades everyday…